Timothy J. Scannell
Timothy J. Scannell was appointed to the Company’s board of directors in March 2022. He also serves as Chair of Insulet Corporation’s board of directors and serves on the board of directors for Novocure and Collagen Matrix. Additionally, Mr. Scannell serves as an Executive Advisor at Stryker, one of the world’s leading medical technology companies. His career at Stryker spans 30+ years, during which he held several leadership roles, including President and Chief Operating Officer, Group President of MedSurg & Neurotechnology, President of Spine, and Vice President & General Manager of Stryker Biotech.
Mr. Scannell brings extensive strategic, sales and marketing, and operational skills and experience, with a track record for delivering top tier results. He holds Bachelor of Business Administration and Master of Business Administration degrees from the University of Notre Dame.